Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1119]

PIONEER research associates from both academic and industry discuss their...

Claudio Sartini, Katharina Beyer, Eleni Vradi, Dr Lisa Morris, Dr Kostas...

PIONEER research associates from both academic and industry discuss their experience of working together ( Claudio Sartini, Katharina Beyer, Eleni Vradi, Dr Lisa Morris, Dr Kostas Dimitropoulos, Dr Peter-Paul Willemse )

Dr Thomas Abbott, EFPIA co-lead for PIONEER, discusses data sources and access...

Dr Thomas Abbott - Head, Real World Evidence at Astellas Pharmaceuticals

Dr Thomas Abbott, EFPIA co-lead for PIONEER, discusses data sources and access to data ( Dr Thomas Abbott - Head, Real World Evidence at Astellas Pharmaceuticals )

Dr Zsuzsanna Devecseri, EFPIA co-lead for PIONEER, discusses prostate cancer...

Dr Zsuzsanna Devecseri - Head, Global Oncology Medical, Sanofi

Dr Zsuzsanna Devecseri, EFPIA co-lead for PIONEER, discusses prostate cancer outcomes ( Dr Zsuzsanna Devecseri - Head, Global Oncology Medical, Sanofi )

Controversies in the management of prostate cancer

Prof Mach Roach III - University of California, San Francisco, USA

Controversies in the management of prostate cancer ( Prof Mach Roach III - University of California, San Francisco, USA )

Local treatment in oligometastatic prostate cancer: Radiotherapy

Prof Mach Roach III - University of California, San Francisco, USA

Local treatment in oligometastatic prostate cancer: Radiotherapy ( Prof Mach Roach III - University of California, San Francisco, USA )

SBRT photons, protons or carbon for prostate cancer: How good is the data?

Prof Mach Roach III - University of California, San Francisco, USA

SBRT photons, protons or carbon for prostate cancer: How good is the data? ( Prof Mach Roach III - University of California, San Francisco, USA )

Differences in hormone therapy for patients with advanced metastatic prostate...

Prof Axel Merseburger - University Hospital Schleswig-Holstein, Lübeck, Germany

Differences in hormone therapy for patients with advanced metastatic prostate cancer ( Prof Axel Merseburger - University Hospital Schleswig-Holstein, Lübeck, Germany )

State of art in systemic management of nmCRPC

Prof Stéphane Oudard - Georges Pompidou Hospital, Paris, France

State of art in systemic management of nmCRPC ( Prof Stéphane Oudard - Georges Pompidou Hospital, Paris, France )

EAU prostate cancer guidelines 2019: What changed and why?

Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France

EAU prostate cancer guidelines 2019: What changed and why? ( Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France )

Neoadjuvant treatment before radical prostatectomy: Current situation

Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France

Neoadjuvant treatment before radical prostatectomy: Current situation ( Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France )

First- and second-line treatments for locally advanced renal cell carcinoma

Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA

First- and second-line treatments for locally advanced renal cell carcinoma ( Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA )

Emerging management of metastatic castration-sensitive prostate cancer: front...

Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA

Emerging management of metastatic castration-sensitive prostate cancer: front-line chemotherapy vs. oral therapy ( Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA )

More from ecancer